Decoding the complexity of type I interferon to treat persistent viral infections
about
The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferonsType I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.Bacterial expression and preliminary crystallographic studies of a 149-residue fragment of human Caprin-1.Human pDCs preferentially sense enveloped hepatitis A virions.Epigenetic manipulation restores functions of defective CD8⁺ T cells from chronic viral infectionThe role of type I interferons in intestinal infection, homeostasis, and inflammation.Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women.Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement.Targeting type I interferon-mediated activation restores immune function in chronic HIV infection.The unique immunological and microbial aspects of pregnancy.[Plasmacytoid dendritic cells: the novel Eldorado for antiviral therapy?].Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication
P2860
Q33563711-8E2F69FB-6603-46F2-B0E8-DEC6DCFF4FBAQ33665625-D3B11918-83F5-4F76-8058-BD7A369D9102Q34871440-FB630C0A-A59A-40B8-955B-17E6C24E88EEQ35167528-5A070BA2-B49A-4559-A8F4-ED94D8876735Q35242599-23DB3401-CB33-4350-BEC3-DF435DC71D68Q35618602-5A9F300B-31E0-4A3E-9AFD-0A4785DF1433Q36001052-63250B4D-186E-4E78-81D9-5A35B983C81AQ36302403-2E2A6688-C4D0-46C4-A026-564B434CCEB7Q36601983-8FFF3284-3304-424A-A1D1-BC50181E8CC8Q37642643-C282142B-011C-4F49-B889-EE9ED9597F01Q39110897-D325D866-4429-40FC-A73B-F5D82C733FEFQ39382358-1C5069D2-4428-4084-8755-6845AB37D65BQ40932064-39F0B192-90B2-4E98-83B1-E608D7914D07Q47558114-74C7AAD3-F674-44FB-820B-3CA92DB11D67Q58704921-04C1EE68-1D6D-4B2C-90EC-4CBB10CCB4A3
P2860
Decoding the complexity of type I interferon to treat persistent viral infections
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Decoding the complexity of type I interferon to treat persistent viral infections
@ast
Decoding the complexity of type I interferon to treat persistent viral infections
@en
Decoding the complexity of type I interferon to treat persistent viral infections
@nl
type
label
Decoding the complexity of type I interferon to treat persistent viral infections
@ast
Decoding the complexity of type I interferon to treat persistent viral infections
@en
Decoding the complexity of type I interferon to treat persistent viral infections
@nl
prefLabel
Decoding the complexity of type I interferon to treat persistent viral infections
@ast
Decoding the complexity of type I interferon to treat persistent viral infections
@en
Decoding the complexity of type I interferon to treat persistent viral infections
@nl
P2860
P1476
Decoding the complexity of type I interferon to treat persistent viral infections
@en
P2093
David G. Brooks
Elizabeth B. Wilson
P2860
P304
P356
10.1016/J.TIM.2013.10.003
P407
P577
2013-12-01T00:00:00Z